Motility Disorders and Hirschsprung Disease

Published on 27/03/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2060 times

Chapter 324 Motility Disorders and Hirschsprung Disease

324.1 Chronic Intestinal Pseudo-Obstruction

Chronic intestinal pseudo-obstruction comprises a group of disorders characterized by signs and symptoms of intestinal obstruction in the absence of an anatomic lesion. Pseudo-obstruction can occur as a primary disease or be secondary to a large number of conditions that can transiently or permanently alter bowel motility. Pseudo-obstruction represents a wide spectrum of pathologic disorders from abnormal myoelectric activity to abnormalities of the nerves (intestinal neuropathy) or musculature (intestinal myopathy) of the gut. The organs involved can include the entire gastrointestinal tract or be limited to certain components, such as the stomach or colon. The distinctive pathologic abnormalities are considered together because of their clinical similarities.

Most congenital forms of pseudo-obstruction occur sporadically. A few clusters of autosomal dominant or recessive patients have been reported as having cases associated with abnormal gut muscle or nerves. Patients with autosomal dominant forms of pseudo-obstruction have variable expressions of the disease. Acquired pseudo-obstruction can follow episodes of acute gastroenteritis, presumably resulting in injury to the myenteric plexus.

In congenital pseudo-obstruction, abnormalities of the muscle or nerves can be demonstrated in most cases. In muscular disease, the outer longitudinal muscle layer is replaced by fibrous material. In neuronal disease, there may be disorganized ganglia, hypoganglionosis, or hyperganglionosis. Abnormalities in the interstitial cells of Cajal (potential gut pacemaker) have been demonstrated in some children and mitochondrial defects have been found in others. Genetic defects have been identified in the transcription factor SOX10, the DNA polymerase gamma gene (POLG), and a locus on chromosome 8.

Clinical Manifestations

More than half the children with congenital pseudo-obstruction experience symptoms in the first few months of life. Two thirds of the infants presenting in the first few days of life are born prematurely, and about 40% have malrotation of the intestine. In 75% of all affected children, symptoms occur in the first year of life, and the remainder become symptomatic in the next several years. The most common symptoms are abdominal distention and vomiting, which are present in 75% of affected infants. Constipation, growth failure, and abdominal pain occur in about 60% of patients, and diarrhea occurs in 30-40%. The symptoms wax and wane in the majority of the patients; poor nutrition, psychological stress, and intercurrent illness tend to exacerbate symptoms. Urinary tract and bladder involvement occurs in 80% of children with myopathic pseudo-obstruction and in 20% of those with neuropathic disease. Symptoms can manifest as recurrent urinary tract infection, megacystis, or obstructive symptoms.

The diagnosis of pseudo-obstruction is based on the presence of compatible symptoms in the absence of anatomic obstruction. Plain abdominal radiographs demonstrate air-fluid levels in the small intestine. Neonates with evidence of obstruction at birth have a microcolon. Contrast studies demonstrate slow passage of barium; water-soluble agents should be considered. Esophageal motility is abnormal in about half the patients. Antroduodenal motility and gastric emptying studies have abnormal results if the upper gut is involved (Table 324-1). Manometric evidence of a normal migrating motor complex and postprandial activity should redirect the diagnostic evaluation. Anorectal motility is normal and differentiates pseudo-obstruction from Hirschsprung disease. Full-thickness intestinal biopsy might show involvement of the muscle layers or abnormalities of the intrinsic intestinal nervous system.

Table 324-1 FINDINGS IN PSEUDO-OBSTRUCTION

GI SEGMENT FINDINGS*
Esophageal motility Abnormalities in approximately half of CIPO, although in some series up to 85% demonstrate abnormalities
Decreased LES pressure
Failure of LES relaxation
Esophageal body: low-amplitude waves, poor propagation, tertiary waves, retrograde peristalsis, occasionally aperistalsis
Gastric emptying May be delayed
ECG Tachygastria or bradygastria may be seen
ADM Postprandial antral hypomobility is seen and correlates with delayed gastric emptying
Myopathic subtype: low-amplitude contractions, <10-20 mm Hg
Neuropathic subtype: contractions are uncoordinated
Fed response is absent
Fasting MMC is absent, or MMC is abnormally propagated
Colonic No gastric reflex because there is no increased motility in response to a meal
ARM Normal rectoanal inhibitory reflex (RAIR)

ADM, antroduodenal manometry; ARM, anorectal manometry; CIPO, chronic intestinal pseudo-obstruction; EGG, electrogastrography; GI, gastrointestinal; LES, lower esophageal sphincter; MMC, migrating motor complex.

* Findings can vary according to the segment(s) of the gastrointestinal tract that are involved.

From Wyllie R, Hyams JS, editors: Pediatric gastrointestinal and liver disease, ed 3, Philadelphia, 2006, Saunders.

The differential diagnosis includes Hirschsprung disease, other causes of mechanical obstruction, psychogenic constipation, neurogenic bladder, and superior mesenteric artery syndrome. Secondary causes of ileus or pseudo-obstruction, such as hypothyroidism, opiates, scleroderma, Chagas disease, hypokalemia, diabetic neuropathy, amyloidosis, porphyria, angioneurotic edema, mitochondrial disorders, and radiation, must be excluded.

Treatment

Nutritional support is the mainstay of treatment for pseudo-obstruction. Thirty to 50% require partial or complete parenteral nutrition. Some patients can be treated with intermittent enteral supplementation, whereas others can maintain themselves on selective oral diets. Prokinetic drugs are generally not useful. Isolated gastroparesis can follow episodes of viral gastroenteritis and spontaneously resolves, usually in 6-24 mo. Erythromycin, a motilin receptor agonist, and cisapride, a serotonin 5-HT4 receptor agonist, can enhance gastric emptying and proximal small bowel motility and may be of use in this selected group of patients. Pain management is difficult and requires a multidisciplinary approach.

Symptomatic small bowel bacterial overgrowth is usually treated with oral antibiotics or probiotics. Bacterial overgrowth can be associated with steatorrhea and malabsorption. Although unabsorbable antibiotics remain the treatment of choice, courses of other antibiotics may be introduced and used judiciously to help counteract the possible emergence of drug-resistant bacteria. The long-acting somatostatin analog octreotide has been used in low doses to treat small bowel bacterial overgrowth. Patients with acid peptic symptoms are treated with acid suppressors. Many benefit from a gastrostomy and some benefit from decompressive ileostomies or colostomies. Colectomy with ileorectal anastomosis is beneficial if the large bowel is the primary site of the motility abnormality. Bowel transplantation can benefit selected patients.

324.2 Functional Constipation

Constipation is defined by a delay or difficulty in defecation present for 2 weeks or longer and significant to cause distress to the patient. Another approach to the definition is noted in Table 324-2. Functional constipation, also known as idiopathic constipation or fecal withholding, can usually be differentiated from constipation secondary to organic causes on the basis of a history and physical examination (Chapter 21.4). Unlike anorectal malformations and Hirschsprung disease, functional constipation typically starts after the neonatal period. Usually, there is an intentional or subconscious withholding of stool. An acute episode usually precedes the chronic course. The acute episode may be a dietary change from human milk to cow’s milk, secondary to the change in protein:carbohydrate ratio or an allergy to cow’s milk. The stool becomes firm, smaller, and difficult to pass, resulting in anal irritation and often an anal fissure. In toddlers, coercive or inappropriately early toilet training is a factor that can initiate a pattern of stool retention. In older children, retentive constipation can develop after entering a situation that makes stooling inconvenient such as school. Because the passage of bowel movements is painful, voluntary withholding of feces to avoid the painful stimulus develops.

When children have the urge to defecate, typical behaviors include contracting the gluteal muscles by stiffening the legs while lying down, holding onto furniture while standing, or squatting quietly in corners, waiting for the call to stool to pass. The urge to defecate passes as the rectum accommodates to its contents. A vicious cycle of retention develops as increasingly larger volumes of stool need to be expelled. Caregivers might misinterpret these activities as straining, but it is withholding behavior. In functional constipation, daytime encopresis is common, and some children have a history of blood in the stool noted with the passage of a large bowel movement. Findings suggestive of underlying pathology include failure to thrive, weight loss, abdominal pain, vomiting, or persistent anal fissure or fistula.

The physical examination often demonstrates a large volume of stool palpated in the suprapubic area; rectal examination demonstrates a dilated rectal vault filled with guaiac-negative stool. The presence of a hair tuft over the spine or spinal dimple, or failure to elicit a cremasteric reflex or anal wink suggests spinal pathology. A tethered cord is suggested by decreased or absent lower leg reflexes. Spinal cord lesions can occur with overlying skin anomalies. Urinary tract symptoms include recurrent urinary tract infection and enuresis. Children with no evidence of abnormalities on physical examination rarely require radiologic evaluation.

In refractory patients (intractable constipation), specialized testing should be considered to rule out conditions such as hypothyroidism, hypocalcemia, lead toxicity, celiac disease, and allergy testing. Colonic transit studies using radio-opaque markers or scintigraphy techniques may be useful. Selected children can benefit from MRI of the spine to identify an intraspinal process, motility studies to identify underlying myopathic or neuropathic bowel abnormalities, or a barium enema to identify structural abnormalities. Anorectal motility studies can demonstrate a pattern of paradoxical contraction of the external anal sphincter during defecation, which can be treated by behavior modification. Colonic motility can guide therapy in refractory cases, demonstrating segmental problems that might require surgical intervention.

Therapy for functional constipation includes patient education, relief of impaction, and softening of the stool (Chapter 21.4). The parents must understand that soiling associated with overflow incontinence is associated with loss of normal sensation and not a willful act. A regular bowel training program, including sitting on the toilet for 5-10 min after meals and keeping track of the frequency of bowel movements, is often helpful in establishing a regular bowel habit. If an impaction is present on the initial physical examination, an enema is usually required to clear the impaction while bowel softeners are started as maintenance medications. Typical regimens include the use of polyethylene glycol preparations, lactulose, or mineral oil. Prolonged use of stimulants such as senna or bisacodyl should be avoided. Children with behavioral problems that are interfering with successful treatment might benefit from a referral to a mental heath care provider. Maintenance therapy is generally continued until a regular bowel pattern has been established and the association of pain with the passage of stool is abolished. Children with spinal problems can be successfully managed with low volumes of fluid through a cecostomy or sigmoid tube.

Bibliography

Bekkali NLH, van den Berg MM, Dijkgraaf MGW, et al. Rectal fecal impaction treatment in childhood constipation: enemas versus high doses oral PEG. Pediatrics. 2009;124:e1108-e1115.

Camilleri M, Kerstens R, Rykx A, et al. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med. 2008;358:2344-2354.

Candy D, Belsey J. Macrogol (polyethylene glycol) laxatives in children with functional constipation and faecal impaction: a systematic review. Arch Dis Child. 2009;94:156-160.

Carvalho RS, Michail SK, Ashai-Khan F, et al. An update in pediatric gastroenterology and nutrition: a review of some recent advances. Curr Prob Pediatr Adolesc Health Care. 2008;38:197-234.

Hutson J, McNamara J, Shin Y. Review article: slow transit constipation in children. J Paediatr Child Health. 2001;37:426-430.

Emmanuel AV, Kamm MA. Response to a behavioral treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation. Gut. 2001;49:214-219.

Masi P, Miele E, Staiano A. Pediatric anorectal disorders. Gastroenterol Clin N Am. 2008;37:709-730.

Pijpers M, Tabbers M, Benninga M, et al. Currently recommended treatments of childhood constipation are not evidence based: a systematic literature review on the effect of laxative treatment and dietary measures. Arch Dis Child. 2009;94:117-131.

Rosen R, Buonomo C, Andrade R, et al. Incidence of spinal cord lesions in patients with intractable constipation. J Pediatr. 2004;145:409-411.

Van de Berg M, Benninga M, DiLorenzo C. Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol. 2006;101:2401-2409.

Van Dijk M, Benninga M, Grootenhuis M, et al. Chronic childhood constipation: a review of the literature and the introduction of a protocolized behavioral intervention program. Patient Educ Couns. 2007;67(1–2):63-77.

Walker WA, Goulet O, Kleinman R, et al. Pediatric gastrointestinal disease, ed 4. Hamilton, Ontario: BC Decker; 2004.

324.3 Congenital Aganglionic Megacolon (Hirschsprung Disease)

Hirschsprung disease, or congenital aganglionic megacolon, is a developmental disorder (neurocristopathy) of the enteric nervous system, characterized by the absence of ganglion cells in the submucosal and myenteric plexus. It is the most common cause of lower intestinal obstruction in neonates, with an overall incidence of 1 in 5,000 live births. The male:female ratio for Hirschprung disease is 4 : 1 for short-segment disease and closer to 1 : 1 as the length of the involved segment increase. Prematurity is uncommon.

There is an increased familial incidence in long-segment disease. Hirschsprung disease may be associated with other congenital defects, including Down, Goldberg-Shprintzen, Smith-Lemli-Opitz, Shah-Waardenburg, cartilage-hair hypoplasia, and congenital hypoventilation (Ondine’s curse) syndromes and urogenital or cardiovascular abnormalities. Hirschsprung disease has been seen in association with microcephaly, mental retardation, abnormal facies, autism, cleft palate, hydrocephalus, and micrognathia.

Clinical Manifestations

Hirschsprung disease is usually diagnosed in the neonatal period secondary to a distended abdomen, failure to pass meconium, and/or bilious emesis or aspirates with feeding intolerance. In 99% of healthy full-term infants, meconium is passed within 48 hr of birth. Hirschsprung disease should be suspected in any full-term infant (the disease is unusual in preterm infants) with delayed passage of stool. Some neonates pass meconium normally but subsequently present with a history of chronic constipation. Failure to thrive with hypoproteinemia from protein-losing enteropathy is a less common presentation because Hirschsprung disease is usually recognized early in the course of the illness. Breast-fed infants might not suffer disease as severe as formula-fed infants.

Failure to pass stool leads to dilatation of the proximal bowel and abdominal distention. As the bowel dilates, intraluminal pressure increases, resulting in decreased blood flow and deterioration of the mucosal barrier. Stasis allows proliferation of bacteria, which can lead to enterocolitis (Clostridium difficile, Staphylococcus aureus, anaerobes, coliforms) with associated diarrhea, abdominal tenderness, sepsis and signs of bowel obstruction. Early recognition of Hirschsprung disease before the onset of enterocolitis is essential in reducing morbidity and mortality.

Hirschsprung disease in older patients must be distinguished from other causes of abdominal distention and chronic constipation (Table 324-3 and Fig. 324-1). The history often reveals constipation starting in infancy that has responded poorly to medical management. Fecal incontinence, fecal urgency, and stool-withholding behaviors are usually not present. The abdomen is tympanitic and distended, with a large fecal mass palpable in the left lower abdomen. Rectal examination demonstrates a normally placed anus that easily allows entry of the finger but feels snug. The rectum is usually empty of feces, and when the finger is removed, there may be an explosive discharge of foul-smelling feces and gas. The stools, when passed, can consist of small pellets, be ribbon-like, or have a fluid consistency, unlike the large stools seen in patients with functional constipation. Intermittent attacks of intestinal obstruction from retained feces may be associated with pain and fever. Urinary retention with enlarged balder or hydronephrosis can occur secondary to urinary compression.

Table 324-3 DISTINGUISHING FEATURES OF HIRSCHSPRUNG DISEASE AND FUNCTIONAL CONSTIPATION

VARIABLE FUNCTIONAL HIRSCHSPRUNG DISEASE
HISTORY
Onset of constipation After 2 yr of age At birth
Encopresis Common Very rare
Failure to thrive Uncommon Possible
Enterocolitis None Possible
Forced bowel training Usual None
EXAMINATION
Abdominal distention Uncommon Common
Poor weight gain Rare Common
Rectum Filled with stool Empty
Rectal Examination Stool in rectum Explosive passage of stool
Malnutrition None Possible
INVESTIGATIONS
Anorectal manometry Relaxation of internal anal sphincter Failure of internal anal sphincter relaxation
Rectal biopsy Normal No ganglion cells, increased acetylcholinesterase staining
Barium enema Massive amounts of stool, no transition zone Transition zone, delayed evacuation (>24 hr)

In neonates, Hirschsprung disease must be differentiated from meconium plug syndrome, meconium ileus, and intestinal atresia. In older patients, the Currarino triad must be considered, which includes anorectal malformations (ectopic anus, anal stenosis, imperforate anus), sacral bone anomalies (hypoplasia, poor segmentation), and presacral anomaly (anterior meningoceles, teratoma, cyst).

Diagnosis

Rectal suction biopsy is the gold standard for diagnosing Hirschsprung disease. The biopsy material should contain an adequate amount of submucosa to evaluate for the presence of ganglion cells. To avoid obtaining biopsies in the normal area of hypoganglionosis, which ranges from 3 to 17 mm in length, the suction rectal biopsy should be obtained no closer than 2 cm above the dentate line. The biopsy specimen should be stained for acetylcholinesterase to facilitate interpretation. Patients with aganglionosis demonstrate a large number of hypertrophied nerve bundles that stain positively for acetylcholinesterase with an absence of ganglion cells.

Anorectal manometry measures the pressure of the internal anal sphincter while a balloon is distended in the rectum. In normal patients, rectal distention initiates relaxation of the internal anal sphincter in response to rectal distention with a balloon. In patients with Hirschsprung disease, the internal anal sphincter fails to relax in response to rectal distention. Although the sensitivity and specificity can vary widely, in experienced hands, the test can be quite sensitive. The test, however, can be technically difficult to perform in young infants. A normal response in the course of manometric evaluation precludes a diagnosis of Hirschsprung disease; an equivocal or paradoxical response requires a repeat motility or rectal biopsy.

An unprepared contrast enema is most likely to aid in the diagnosis in children older than 1 mo because the proximal ganglionic segment might not be significantly dilated in the first few weeks of life. Classic findings are based on the presence of an abrupt narrow transition zone between the normal dilated proximal colon and a smaller-caliber obstructed distal aganglionic segment. In the absence of this finding, it is imperative to compare the diameter of the rectum to that of the sigmoid colon, because a rectal diameter that is the same as or smaller than the sigmoid colon suggests Hirschsprung disease. Radiologic evaluation should be performed without preparation to prevent transient dilatation of the aganglionic segment. As many as 10% of newborns with Hirschsprung disease have a normal contrast study. Twenty-four hour delayed films are helpful in showing retained contrast (Fig. 324-2). If significant barium is still present in the colon, it increases the suspicion of Hirschsprung disease even if a transition zone is not identified. Barium enema examination is useful in determining the extent of aganglionosis before surgery and in evaluating other diseases that manifest as lower bowel obstruction in a neonate. Full-thickness rectal biopsies can be performed at the time of surgery to confirm the diagnosis and level of involvement.

Treatment

Once the diagnosis is established, the definitive treatment is operative intervention. Previously, a temporary ostomy was placed and definitive surgery was delayed until the child was older. Currently, many infants undergo a primary pull-through procedure except if there is associated enterocolitis or other complications, when a decompressing ostomy is usually required.

There are 3 basic surgical options. The first successful surgical procedure, described by Swenson, was to excise the aganglionic segment and anastomose the normal proximal bowel to the rectum 1-2 cm above the dentate line. The operation is technically difficult and led to the development of 2 other procedures. Duhamel described a procedure to create a neorectum, bringing down normally innervated bowel behind the aganglionic rectum. The neorectum created in this procedure has an anterior aganglionic half with normal sensation and a posterior ganglionic half with normal propulsion. The endorectal pull-through procedure described by Soave involves stripping the mucosa from the aganglionic rectum and bringing normally innervated colon through the residual muscular cuff, thus bypassing the abnormal bowel from within. Advances in techniques have led to successful laparoscopic single-stage endorectal pull-through procedures, which are the treatment of choice.

In ultrashort-segment Hirschsprung disease or internal sphincter achalasia, the aganglionic segment is limited to the internal sphincter. The clinical symptoms are similar to those of children with functional constipation. Ganglion cells are present on rectal suction biopsy, but the anorectal manometry is abnormal, with failure of relaxation of the internal anal sphincter in response to rectal distention. Current treatment, although still controversial, includes anal botulism injection to relax the anal sphincter and anorectal myectomy if indicated.

Long-segment Hirschsprung disease involving the entire colon and, at times, part of the small bowel presents a difficult problem. Anorectal manometry and rectal suction biopsy demonstrate findings of Hirschsprung disease, but radiologic studies are difficult to interpret because a colonic transition zone cannot be identified. The extent of aganglionosis can be determined accurately by biopsy at the time of laparotomy. When the entire colon is aganglionic, often together with a length of terminal ileum, ileal-anal anastomosis is the treatment of choice, preserving part of the aganglionic colon to facilitate water absorption, which helps the stools to become firm.

The prognosis of surgically treated Hirschsprung disease is generally satisfactory; the great majority of patients achieve fecal continence. Long-term postoperative problems include constipation, recurrent enterocolitis, stricture, prolapse, perianal abscesses, and fecal soiling. Some children require myectomy or a redo pull-through procedure.

Bibliography

Bonnard A, Zeidan S, Degas V, et al. Outcomes of Hirschsprung’s disease assocated with Mowat-Wilson syndrome. J Pediatr Surg. 2009;44:587-591.

Dasgupta R, Langer J. Hirschsprung disease. Curr Probl Surg. 2004;41:942-988.

Dasgupta R, Langer J. Evaluation and management of persistent problems after surgery for Hirschsprung disease in a child. J Pediatr Gastroenterol Nutr. 2008;46(1):13-19.

DeLorijn F, Reitsma JB, Voskuijl WP, et al. Diagnosis of Hirschsprung’s disease: a prospective comparative accuracy study of common tests. J Pediatr. 2005;146:787-792.

Hackam D, Reblock K, Barksdale E, et al. The influence of Down’s syndrome on the management and outcome of children with Hirschsprung’s disease. J Pediatr Surg. 2003;38:946-949.

Haricharan R, Georgeson K. Hirschsprung disease. Semin Pediatr Surg. 2008;17:266-275.

Keshtgar AS, Ward HC, Clayden GS, et al. Investigations for incontinence and constipation after surgery for Hirschsprung’s disease in children. Pediatr Surg Int. 2003;19:4-8.

Langer JC, Durrant AC, de la Torre L, et al. One-stage transanal Soave pull through for Hirschsprung disease: a multicenter experience with 141 children. Ann Surg. 2003;238:569-583. discussion 583–585

Pensabene L, Youssef NN, Griffiths JM, et al. Colonic manometry in children with defecatory disorders. Role in diagnosis and management. Am J Gastroenterol. 2003;98:1052-1057.

Prato AP, Musso M, Ceccherini I, et al. Hirschsprung disease and congenital anomalies of the kidney and urinary tract (CAKUT). Medicine. 2009;88:83-90.

Walker WA, Goulet O, Kleinman R, et al. Pediatric gastrointestinal disease, ed 4. Hamilton, Ontario: BC Decker; 2004.

324.4 Intestinal Neuronal Dysplasia

Intestinal neuronal dysplasia (IND) describes different quantitative (hypo- or hyperganglionosis) and qualitative (immature or heterotropic ganglion cells) abnormalities of the myenteric and/or submucous plexus. The typical histology is that of hyperganglionosis and giant ganglia. Type A occurs very rarely and is characterized by congenital aplasia or hypoplasia of the sympathetic innervation. Patients present early in the neonatal period with episodes of intestinal obstruction, diarrhea, and bloody stools. Type B, which accounts for >95% of cases, is characterized by malformation of the parasympathetic submucous and myenteric plexus with giant ganglia and thickened nerve fibers, increased acetylcholinesterase staining, and isolated ganglion cells in the lamina propria. IND type B mimics Hirschsprung disease, and patients present with chronic constipation.

Clinical manifestations include abdominal distention, constipation, and enterocolitis. Various lengths of bowel may be affected from segmental to the entire intestinal tract. IND has been observed in an isolated form and proximal to an aganglionic segment. Other intra- and extraintestinal manifestations are present in patients with IND. It has been reported in all age groups, most commonly in infancy, but is also seen in adults who have had constipation not dating back to childhood.

Associated diseases and conditions include Hirschsprung disease, prematurity, small left colon syndrome, and meconium plug syndrome. Studies have identified a deficiency in substance P in patients with IND. No mutations in the coding regions of the RET, GDNF, EDNRB, or EDN3 genes have been identified.

Management includes that for functional constipation and, if unsuccessful, surgery is indicated.

324.5 Superior Mesenteric Artery Syndrome (Wilkie Syndrome, Cast Syndrome, Arteriomesenteric Duodenal Compression Syndrome)

Superior mesenteric artery syndrome results from compression of the 3rd duodenal segment by the artery against the aorta. Weight loss from malnutrition or catabolic states can cause mesenteric fat depletion, which collapses the duodenum within a narrowed aortomesenteric angle. Other etiologies include extra-abdominal compression (e.g., body cast) and mesenteric tension, as can occur from ileo-anal pouch anastomosis.

Symptoms include intermittent epigastric pain, anorexia, nausea, and vomiting. Associated factors include thin body habitus, prolonged bed rest, abdominal surgery, and exaggerated lumbar lordosis. Onset can be within weeks of a trigger, but some patients have chronic symptoms that evade diagnosis. A classic example is an underweight adolescent who begins vomiting 1-2 wk following scoliosis surgery.

The diagnosis is established radiologically by demonstrating a duodenal cutoff just right of midline along with proximal duodenal dilatation, with or without gastric dilatation. Although the upper gastrointestinal series remains a mainstay, modalities including CT, MR angiography, or ultrasound may be more appropriate if there is concern for other etiologies like malignancy. Upper endoscopy should be considered to rule out intraluminal pathology.

Treatment focuses on obstructive relief and nutritional rehabilitation. Lateral or prone positioning can shift the duodenum away from obstructing structures and allow resumption of oral intake. In such cases, prokinetic agents such as metoclopramide may be helpful. If repositioning is unsuccessful, patients require nasojejunal enteral nutrition past the obstruction or, if this is not tolerated, total parenteral nutrition. Rarely, patients with refractory courses require surgery to bypass the obstruction.